Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Microbiología (26)

2024

  1. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

2022

  1. Age-dependent nasal immune responses in non-hospitalized bronchiolitis children

    Frontiers in Immunology, Vol. 13

2021

  1. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

2020

  1. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Clonal transmission of NDM-5-producing Escherichia coli belonging to high-risk sequence type ST405

    International Journal of Antimicrobial Agents

  2. Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

    Eurosurveillance, Vol. 23, Núm. 9

  3. Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

    Eurosurveillance, Vol. 23, Núm. 7

  4. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency

    Journal of Clinical Immunology, Vol. 38, Núm. 4, pp. 513-526

  5. Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3283-3287

  2. Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis

    Eurosurveillance, Vol. 22, Núm. 7

  3. Inactivation of the thymidylate synthase thyA in non-typeable Haemophilus influenzae modulates antibiotic resistance and has a strong impact on its interplay with the host airways

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. JUN

  4. Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season

    Eurosurveillance, Vol. 22, Núm. 41

  5. The carbapenemase-producing Klebsiella pneumoniae population is distinct and more clonal than the carbapenem-susceptible population

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

2016

  1. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons

    Vaccine, Vol. 34, Núm. 11, pp. 1350-1357

2015

  1. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

    Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 7, pp. 1626-1633

2014

  1. La amenaza de las enterobacterias productoras de carbapenemasas en España: Documento de posicionamiento de los grupos de estudio GEIH y GEMARA de la SEIMC

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 10, pp. 666-670

  2. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

    Eurosurveillance, Vol. 19, Núm. 6

2012

  1. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: Molecular basis, clinical risk factors, and outcome

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 420-427